{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T21:58:13Z","timestamp":1775080693367,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100011541","name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s10549-021-06410-5","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T16:25:43Z","timestamp":1634315143000},"page":"159-167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Uptake and timing of bilateral and contralateral risk-reducing mastectomy in women with Li\u2013Fraumeni syndrome"],"prefix":"10.1007","volume":"191","author":[{"given":"Atara","family":"Siegel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renee C.","family":"Bremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William M. P.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon A.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer T.","family":"Loud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2473-7800","authenticated-orcid":false,"given":"Payal P.","family":"Khincha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"key":"6410_CR1","volume-title":"GeneReviews((R))","author":"K Schneider","year":"1993","unstructured":"Schneider K, Zelley K, Nichols KE, Garber J (1993) Li\u2013Fraumeni syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K et al (eds) GeneReviews((R)). Springer, Seattle"},{"issue":"4","key":"6410_CR2","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1177\/1947601911413466","volume":"2","author":"D Malkin","year":"2011","unstructured":"Malkin D (2011) Li\u2013Fraumeni syndrome. Genes Cancer 2(4):475\u2013484","journal-title":"Genes Cancer"},{"issue":"23","key":"6410_CR3","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1002\/cncr.30248","volume":"122","author":"PL Mai","year":"2016","unstructured":"Mai PL, Best AF, Peters JA, DeCastro RM, Khincha PP, Loud JT, Bremer RC, Rosenberg PS, Savage SA (2016) Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li\u2013Fraumeni syndrome cohort. Cancer 122(23):3673\u20134368","journal-title":"Cancer"},{"issue":"12","key":"6410_CR4","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1001\/jamaoncol.2017.1968","volume":"3","author":"ML Ballinger","year":"2017","unstructured":"Ballinger ML, Best A, Mai PL, Khincha PP, Loud JT, Peters JA, Achatz MI, Chojniak R, Balieiro da Costa A, Santiago KM, Garber J, O\u2019Neill AF, Eeles RA, Evans DG, Bleiker E, Sonke GS, Ruijs M, Loo C, Schiffman J, Naumer A, Kohlmann W, Strong LC, Bojadzieva J, Malkin D, Rednam SP, Stoffel EM, Koeppe E, Weitzel JN, Slavin TP, Nehoray B, Robson M, Walsh M, Manelli L, Villani A, Thomas DM, Savage SA (2017) Baseline surveillance in Li\u2013Fraumeni syndrome using whole-body magnetic resonance imaging: a meta-analysis. JAMA Oncol 3(12):1634\u20131639","journal-title":"JAMA Oncol"},{"issue":"11","key":"6410_CR5","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1158\/1078-0432.CCR-17-0408","volume":"23","author":"CP Kratz","year":"2017","unstructured":"Kratz CP, Achatz MI, Brugi\u00e8res L, Frebourg T, Garber JE, Greer MC, Hansford JR, Janeway KA, Kohlmann WK, McGee R, Mullighan CG, Onel K, Pajtler KW, Pfister SM, Savage SA, Schiffman JD, Schneider KA, Strong LC, Evans DGR, Wasserman JD, Villani A, Malkin D (2017) Cancer screening recommendations for individuals with Li\u2013Fraumeni syndrome. Clin Cancer Res 23(11):e38\u2013e45","journal-title":"Clin Cancer Res"},{"key":"6410_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ejca.2019.05.005","volume":"116","author":"PP Khincha","year":"2019","unstructured":"Khincha PP, Best AF, Fraumeni JF Jr, Loud JT, Savage SA, Achatz MI (2019) Reproductive factors associated with breast cancer risk in Li\u2013Fraumeni syndrome. Eur J Cancer 116:199\u2013206","journal-title":"Eur J Cancer"},{"issue":"3","key":"6410_CR7","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s10549-012-1993-9","volume":"133","author":"S Masciari","year":"2012","unstructured":"Masciari S, Dillon DA, Rath M, Robson M, Weitzel JN, Balmana J, Gruber SB, Ford JM, Euhus D, Lebensohn A, Telli M, Pochebit SM, Lypas G, Garber JE (2012) Breast cancer phenotype in women with TP53 germline mutations: a Li\u2013Fraumeni syndrome consortium effort. Breast Cancer Res Treat 133(3):1125\u20131130","journal-title":"Breast Cancer Res Treat"},{"issue":"21","key":"6410_CR8","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","volume":"33","author":"G Bougeard","year":"2015","unstructured":"Bougeard G, Renaux-Petel M, Flaman JM, Charbonnier C, Fermey P, Belotti M, Gauthier-Villars M, Stoppa-Lyonnet D, Consolino E, Brugi\u00e8res L, Caron O, Benusiglio PR, Bressac-de Paillerets B, Bonadona V, Bona\u00efti-Pelli\u00e9 C, Tinat J, Baert-Desurmont S, Frebourg T (2015) Revisiting Li\u2013Fraumeni syndrome from TP53 mutation carriers. J Clin Oncol 33(21):2345\u20132352","journal-title":"J Clin Oncol"},{"key":"6410_CR9","unstructured":"National Comprehensive Cancer Network (2020) Genetic\/familial high-risk assessment: breast, ovarian & pancreatic. (Version 1.2020). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_bop.pdf. Accessed 17 April 2020"},{"issue":"11","key":"6410_CR10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3816\/CBC.2007.n.053","volume":"7","author":"TM Friebel","year":"2007","unstructured":"Friebel TM, Domchek SM, Neuhausen SL, Wagner T, Evans DG, Isaacs C, Garber JE, Daly MB, Eeles R, Matloff E, Tomlinson G, Lynch HT, Tung N, Blum JL, Weitzel J, Rubinstein WS, Ganz PA, Couch F, Rebbeck TR (2007) Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers. Clin Breast Cancer 7(11):875\u2013882","journal-title":"Clin Breast Cancer"},{"issue":"4","key":"6410_CR11","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1399-0004.2009.01329.x","volume":"77","author":"AB Skytte","year":"2010","unstructured":"Skytte AB, Gerdes AM, Andersen MK, Sunde L, Br\u00f8ndum-Nielsen K, Waldstr\u00f8m M, K\u00f8lvraa S, Cr\u00fcger D (2010) Risk-reducing mastectomy and salpingo-oophorectomy in unaffected BRCA mutation carriers: uptake and timing. Clin Genet 77(4):342\u2013349","journal-title":"Clin Genet"},{"issue":"9","key":"6410_CR12","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1002\/ijc.23340","volume":"122","author":"KA Metcalfe","year":"2008","unstructured":"Metcalfe KA, Birenbaum-Carmeli D, Lubinski J, Gronwald J, Lynch H, Moller P, Ghadirian P, Foulkes WD, Klijn J, Friedman E, Kim-Sing C, Ainsworth P, Rosen B, Domchek S, Wagner T, Tung N, Manoukian S, Couch F, Sun P, Narod SA, Hereditary Breast Cancer Clinical Study Group (2008) International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Int J Cancer 122(9):2017\u20132022","journal-title":"Int J Cancer"},{"issue":"10","key":"6410_CR13","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1245\/s10434-017-5976-2","volume":"24","author":"E Gilbert","year":"2017","unstructured":"Gilbert E, Zabor EC, Stempel M, Mangino D, Heerdt A, Pilewskie M (2017) Differences among a modern cohort of BRCA mutation carriers choosing bilateral prophylactic mastectomies compared to breast surveillance. Ann Surg Oncol 24(10):3048\u20133054","journal-title":"Ann Surg Oncol"},{"issue":"14","key":"6410_CR14","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1200\/JCO.2006.10.5494","volume":"26","author":"S van Dijk","year":"2008","unstructured":"van Dijk S, van Roosmalen MS, Otten W, Stalmeier PF (2008) Decision making regarding prophylactic mastectomy: stability of preferences and the impact of anticipated feelings of regret. J Clin Oncol 26(14):2358\u20132363","journal-title":"J Clin Oncol"},{"issue":"4","key":"6410_CR15","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1080\/00981380802173509","volume":"47","author":"A Werner-Lin","year":"2008","unstructured":"Werner-Lin A (2008) Beating the biological clock: the compressed family life cycle of young women with BRCA gene alterations. Soc Work Health Care 47(4):416\u2013437","journal-title":"Soc Work Health Care"},{"issue":"15","key":"6410_CR16","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1158\/1078-0432.CCR-15-1465","volume":"22","author":"X Li","year":"2016","unstructured":"Li X, You R, Wang X, Liu C, Xu Z, Zhou J, Bin Y, Xu T, Cai H, Zou Q (2016) Effectiveness of prophylactic surgeries in BRCA1 or BRCA2 mutation carriers: a meta-analysis and systematic review. Clin Cancer Res 22(15):3971\u20133981","journal-title":"Clin Cancer Res"},{"issue":"4","key":"6410_CR17","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.amjsurg.2016.06.010","volume":"212","author":"KK Ludwig","year":"2016","unstructured":"Ludwig KK, Neuner J, Butler A, Geurts JL, Kong AL (2016) Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review. Am J Surg 212(4):660\u2013669","journal-title":"Am J Surg"},{"issue":"3","key":"6410_CR18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.breast.2011.01.006","volume":"20","author":"I Haroun","year":"2011","unstructured":"Haroun I, Graham T, Poll A, Sun P, Hill K, Weitzner E, Narod S, Warner E (2011) Reasons for risk-reducing mastectomy versus MRI-screening in a cohort of women at high hereditary risk of breast cancer. Breast 20(3):254\u2013258","journal-title":"Breast"},{"issue":"7278","key":"6410_CR19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1136\/bmj.322.7278.76","volume":"322","author":"M Bebbington-Hatcher","year":"2001","unstructured":"Bebbington-Hatcher M, Fallowfield L, A\u2019Hern R (2001) The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews. BMJ 322(7278):76","journal-title":"BMJ"},{"key":"6410_CR20","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1037\/hea0000156","volume":"34","author":"DB Portnoy","year":"2014","unstructured":"Portnoy DB, Loud JT, Han PKJ, Mai PK, Greene MH (2014) Effects of false-positive screenings and worry on risk-reducing surgery among BRCA1\/2 carriers. Health Psychol 34:709\u2013717","journal-title":"Health Psychol"},{"issue":"4","key":"6410_CR21","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.ypmed.2003.11.012","volume":"38","author":"MC Katapodi","year":"2004","unstructured":"Katapodi MC, Lee KA, Facione NC, Dodd MJ (2004) Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic review. Prev Med 38(4):388\u2013402","journal-title":"Prev Med"},{"issue":"1","key":"6410_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejca.2006.09.009","volume":"43","author":"PJ Bresser","year":"2007","unstructured":"Bresser PJ, Seynaeve C, Van Gool AR, Niermeijer MF, Duivenvoorden HJ, van Dooren S, van Geel AN, Menke-Pluijmers MB, Klijn JG, Tibben A (2007) The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and\/or salpingo-oophorectomy. Eur J Cancer 43(1):95\u2013103","journal-title":"Eur J Cancer"},{"issue":"3","key":"6410_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s10689-012-9588-5","volume":"12","author":"JP Gopie","year":"2013","unstructured":"Gopie JP, Mureau MA, Seynaeve C, ter Kuile MM, Menke-Pluymers MB, Timman R, Tibben A (2013) Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer. Fam Cancer 12(3):479\u2013487","journal-title":"Fam Cancer"},{"issue":"12","key":"6410_CR24","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1001\/jamaoncol.2017.1350","volume":"3","author":"PL Mai","year":"2017","unstructured":"Mai PL, Khincha PP, Loud JT, DeCastro RM, Bremer RC, Peters JA, Liu CY, Bluemke DA, Malayeri AA, Savage SA (2017) Prevalence of cancer at baseline screening in the National Cancer Institute Li\u2013Fraumeni syndrome cohort. JAMA Oncol 3(12):1640\u20131645","journal-title":"JAMA Oncol"},{"issue":"4","key":"6410_CR25","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1200\/JCO.1994.12.4.843","volume":"12","author":"C Lerman","year":"1994","unstructured":"Lerman C, Daly M, Masny A, Balshem A (1994) Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 12(4):843\u2013850","journal-title":"J Clin Oncol"},{"issue":"2","key":"6410_CR26","first-page":"169","volume":"4","author":"JP Struewing","year":"1995","unstructured":"Struewing JP, Lerman C, Kase RG, Giambarresi TR, Tucker MA (1995) Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prev 4(2):169\u2013173","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"6410_CR27","volume-title":"Released 2019. IBM SPSS statistics for windows, version 260","author":"IBM Corp","year":"2019","unstructured":"IBM Corp (2019) Released 2019. IBM SPSS statistics for windows, version 260. IBM Corp, Armonk"},{"issue":"7","key":"6410_CR28","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1200\/JCO.2007.12.6078","volume":"26","author":"KA Metcalfe","year":"2008","unstructured":"Metcalfe KA, Lubinski J, Ghadirian P, Lynch H, Kim-Sing C, Friedman E, Foulkes WD, Domchek S, Ainsworth P, Isaacs C, Tung N, Gronwald J, Cummings S, Wagner T, Manoukian S, M\u00f8ller P, Weitzel J, Sun P, Narod SA, Hereditary Breast Cancer Clinical Study Group (2008) Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. J Clin Oncol 26(7):1093\u20131097","journal-title":"J Clin Oncol"},{"issue":"1","key":"6410_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1089\/gtmb.2008.0067","volume":"13","author":"MS Beattie","year":"2009","unstructured":"Beattie MS, Crawford B, Lin F, Vittinghoff E, Ziegler J (2009) Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers. Genet Test Mol Biomarkers 13(1):51\u201356","journal-title":"Genet Test Mol Biomarkers"},{"issue":"2","key":"6410_CR30","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ygyno.2013.12.014","volume":"132","author":"C Garcia","year":"2014","unstructured":"Garcia C, Wendt J, Lyon L, Jones J, Littell RD, Armstrong MA, Raine-Bennett T, Powell CB (2014) Risk management options elected by women after testing positive for a BRCA mutation. Gynecol Oncol 132(2):428\u2013433","journal-title":"Gynecol Oncol"},{"key":"6410_CR31","unstructured":"NCCN: National Comprehensive Cancer Network. Breast cancer. (version 4.2020). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast_blocks.pdf. Accessed 30 June 2020"},{"issue":"11","key":"6410_CR32","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1200\/JCO.1993.11.11.2090","volume":"11","author":"PP Rosen","year":"1993","unstructured":"Rosen PP, Groshen S, Kinne DW et al (1993) Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0\/T2N0M0 patients with long-term follow-up. J Clin Oncol 11(11):2090\u20132100","journal-title":"J Clin Oncol"},{"issue":"11","key":"6410_CR33","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1245\/s10434-011-1914-x","volume":"18","author":"A Abbott","year":"2011","unstructured":"Abbott A, Rueth N, Pappas-Varco S et al (2011) Perceptions of contralateral breast cancer: an overestimation of risk. Ann Surg Oncol 18(11):3129\u20133136","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"6410_CR34","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1200\/JCO.2010.32.7395","volume":"29","author":"HB Nichols","year":"2011","unstructured":"Nichols HB, de Gonz\u00e1lez AB, Lacey JV et al (2011) Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol 29(12):1564\u20131569","journal-title":"J Clin Oncol"},{"issue":"12","key":"6410_CR35","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1002\/1097-0142(20000615)88:12<2739::AID-CNCR12>3.0.CO;2-J","volume":"88","author":"DE Heron","year":"2000","unstructured":"Heron DE, Komarnicky LT, Hyslop T et al (2000) Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Cancer 88(12):2739\u20132750","journal-title":"Cancer"},{"issue":"35","key":"6410_CR36","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.1200\/JCO.2008.19.9430","volume":"27","author":"MK Graeser","year":"2009","unstructured":"Graeser MK, Engel C, Rhiem K et al (2009) Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 27(35):5887\u20135892","journal-title":"J Clin Oncol"},{"issue":"35","key":"6410_CR37","doi-asserted-by":"publisher","first-page":"5862","DOI":"10.1200\/JCO.2009.25.1652","volume":"27","author":"JE Garber","year":"2009","unstructured":"Garber JE, Golshan M (2009) Contralateral breast cancer in BRCA1\/BRCA2 mutation carriers: the story of the other side. J Clin Oncol 27(35):5862\u20135864","journal-title":"J Clin Oncol"},{"key":"6410_CR38","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/cancers12020378","volume":"12","author":"Z Hyder","year":"2020","unstructured":"Hyder Z, Harkness EF, Woodward ER, Bowers NL, Pereira M, Wallace AJ, Howell SJ, Howell A, Lalloo F, Newman WG, Smith MJ, Evans DG (2020) Risk of contralateral breast cancer in women with and without pathogenic variants in BRCA1, BRCA2, and TP53 genes in women with very early-onset (< 36 years) breast cancer. Cancers 12:2","journal-title":"Cancers"},{"key":"6410_CR39","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/COC.0b013e318292f8a7","volume":"38","author":"A Soran","year":"2015","unstructured":"Soran A, Ibrahim A, Kanbour M, McGuire K, Balci FL, Polat A, Thomas C, Bonaventura M, Ahrendt G, Johnson R (2015) Decision making and factors influencing long-term satisfaction with prophylactic mastectomy in women with breast cancer. Am J Clin Oncol 38:2","journal-title":"Am J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-021-06410-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-021-06410-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-021-06410-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T21:03:41Z","timestamp":1642107821000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-021-06410-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["6410"],"URL":"https:\/\/doi.org\/10.1007\/s10549-021-06410-5","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]},"assertion":[{"value":"23 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}